Literature DB >> 15268652

Patients' role in reporting adverse drug reactions.

Kees van Grootheest1, Lolkje de Jong-van den Berg.   

Abstract

This review discusses the involvement of patients in the reporting of adverse drug reactions (ADRs). Patients benefit from drugs but also experience their adverse effects. Since concerns about the safety of drugs are also patients' concerns, the patient could also play a part in decreasing the risks of drug therapy. Patient interest in the safety aspects of drugs is evident. At an international level, the merits of patient reports are being considered. To date, the literature does not yet provide any actual results in relation to the detection of ADRs by patients. Different considerations regarding ADR reporting by patients are discussed. The authors conclude that we should positively value patients' involvement in drug therapy and their concern regarding possible adverse effects. As a consequence, patients' reports on ADRs should be accepted.

Entities:  

Mesh:

Year:  2004        PMID: 15268652     DOI: 10.1517/14740338.3.4.363

Source DB:  PubMed          Journal:  Expert Opin Drug Saf        ISSN: 1474-0338            Impact factor:   4.250


  25 in total

Review 1.  Experiences with adverse drug reaction reporting by patients: an 11-country survey.

Authors:  Florence van Hunsel; Linda Härmark; Shanthi Pal; Sten Olsson; Kees van Grootheest
Journal:  Drug Saf       Date:  2012-01-01       Impact factor: 5.606

2.  Active Extraction of Experience of Adverse Drug Reactions in Children.

Authors:  Aoi Noda; Taku Obara; Michihiro Satoh; Naoto Yagi; Nariyasu Mano; Kenji Kaneko
Journal:  J Pediatr Pharmacol Ther       Date:  2021-05-19

3.  How patient reporters identify adverse drug reactions: a qualitative study of reporting via the UK Yellow Card Scheme.

Authors:  Janet Krska; Claire Anderson; Elizabeth Murphy; Anthony J Avery
Journal:  Drug Saf       Date:  2011-05-01       Impact factor: 5.606

4.  Monitoring adverse events of the vaccination campaign against influenza A (H1N1) in the Netherlands.

Authors:  Eugène P van Puijenbroek; Nancy Broos; Kees van Grootheest
Journal:  Drug Saf       Date:  2010-12-01       Impact factor: 5.606

5.  The importance of direct patient reporting of suspected adverse drug reactions: a patient perspective.

Authors:  Claire Anderson; Janet Krska; Elizabeth Murphy; Anthony Avery
Journal:  Br J Clin Pharmacol       Date:  2011-11       Impact factor: 4.335

Review 6.  Patient reporting of suspected adverse drug reactions: a review of published literature and international experience.

Authors:  A Blenkinsopp; P Wilkie; M Wang; P A Routledge
Journal:  Br J Clin Pharmacol       Date:  2007-02       Impact factor: 4.335

7.  Consumer reporting of adverse drug reactions: a retrospective analysis of the Danish adverse drug reaction database from 2004 to 2006.

Authors:  Lise Aagaard; Lars Hougaard Nielsen; Ebba Holme Hansen
Journal:  Drug Saf       Date:  2009       Impact factor: 5.606

8.  Need for involving consumers in Nepal's pharmacovigilance system.

Authors:  Nisha Jha; Devendra Singh Rathore; P Ravi Shankar; Bhupendra Bahadur Thapa; Gajendra Bhuju; Mohammed Alshakka
Journal:  Australas Med J       Date:  2014-04-30

9.  How do patients contribute to signal detection? : A retrospective analysis of spontaneous reporting of adverse drug reactions in the UK's Yellow Card Scheme.

Authors:  Lorna Hazell; Victoria Cornelius; Philip Hannaford; Saad Shakir; Anthony J Avery
Journal:  Drug Saf       Date:  2013-03       Impact factor: 5.606

10.  Patients' use of information about medicine side effects in relation to experiences of suspected adverse drug reactions: a cross-sectional survey in medical in-patients.

Authors:  Janet Krska; Charles W Morecroft
Journal:  Drug Saf       Date:  2013-08       Impact factor: 5.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.